StoxAcutaas Chemicals vs Neuland Laboratories: share price & financials comparison
NSE: ACUTAAS vs NEULANDLAB · Healthcare · as of 06 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Acutaas Chemicals vs Neuland Laboratories at a glance
Acutaas Chemicals (ACUTAAS) has a market capitalisation of ₹31,001 Cr, against ₹25,414 Cr for Neuland Laboratories (NEULANDLAB). Over the past year Acutaas Chemicals has returned +124.2%, compared with +27.9% for Neuland Laboratories. On valuation, Neuland Laboratories trades at a lower P/E of 56.2 versus 70.6. Acutaas Chemicals earns a higher return on equity (23.6% vs 22.3%). Acutaas Chemicals comes out ahead on profitability, growth, financial health, momentum and technicals. Neuland Laboratories comes out ahead on size and valuation. Across the scored metrics below, Acutaas Chemicals leads on 11 and Neuland Laboratories on 5. On StoxGud's 10-point checklist, Acutaas Chemicals scores 9/10 and Neuland Laboratories scores 7/10.
| Metric | Acutaas Chemicals | Neuland Laboratories |
|---|---|---|
| Size | ||
| Market cap | ₹31,001 Cr | ₹25,414 Cr |
| Revenue (latest FY) | ₹1,339 Cr | ₹2,023 Cr |
| Net profit (latest FY) | ₹356 Cr | ₹364 Cr |
| Valuation | ||
| P/E | 70.6 | 56.2 |
| P/B | 16.69 | 12.52 |
| Dividend yield | 0.04% | 0.06% |
| Profitability | ||
| Return on equity | 23.6% | 22.3% |
| Net profit margin | 27.6% | 19.6% |
| Operating margin | 39.1% | 30.6% |
| Growth | ||
| Revenue growth (YoY) | +42.7% | -12.6% |
| Net profit growth (YoY) | +73.3% | — |
| Revenue CAGR (multi-year) | +26.7% | +16.6% |
| Financial health | ||
| Debt to equity | 0.00 | 0.17 |
| Momentum | ||
| 1-month return | +19.3% | -9.0% |
| 1-year return | +124.2% | +27.9% |
| 3-year CAGR | +87.5% | +69.6% |
| 5-year CAGR | +48.9% | +64.0% |
| 10-year CAGR | — | +34.4% |
| Distance from 52W high | -5.4% | -17.9% |
| Technicals | ||
| RSI (14) | 68 | 50 |
| Price vs 200-day avg | +31.9% | +12.4% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Acutaas Chemicals | Neuland Laboratories |
|---|---|---|
| Price above 50-day average | ✓ | ✗ |
| Price above 200-day average | ✓ | ✓ |
| 50-day average above 200-day (uptrend) | ✓ | ✓ |
| RSI in healthy 40–70 zone | ✓ | ✓ |
| Positive 1-year return | ✓ | ✓ |
| Return on equity above 15% | ✓ | ✓ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✗ |
| Net profit margin above 10% | ✓ | ✓ |
| P/E below industry median | ✗ | ✗ |
| Score | 9/10 | 7/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Acutaas Chemicals or Neuland Laboratories?
Acutaas Chemicals has a market cap of ₹31,001 Cr and Neuland Laboratories has a market cap of ₹25,414 Cr as of 06 Nov 2026.
Which has a lower P/E, Acutaas Chemicals or Neuland Laboratories?
Neuland Laboratories has the lower P/E: Acutaas Chemicals trades at 70.6 and Neuland Laboratories at 56.2.
Which gave better returns in the last year, Acutaas Chemicals or Neuland Laboratories?
Acutaas Chemicals did better: Acutaas Chemicals returned +124.2% and Neuland Laboratories returned +27.9% over one year.
Is Acutaas Chemicals or Neuland Laboratories a better buy?
StoxGud does not give buy or sell recommendations. On our rules-based checklist Acutaas Chemicals scores 9/10 and Neuland Laboratories scores 7/10; compare valuation, profitability, growth and momentum above and consult a SEBI-registered adviser.